Nautilus Biotechnology (NAUT) Property, Plant & Equipment (Net) (QoQ) (2021 - 2026)

Nautilus Biotechnology (NAUT) Property, Plant & Equipment (Net) (QoQ) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Nautilus Biotechnology 212.11 Mn 116.24 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 5.15%
Dec 31, 2025 -4.61%
Sep 30, 2025 -2.79%
Jun 30, 2025 -1.64%
Mar 31, 2025 -7.02%
Dec 31, 2024 -5.74%
Sep 30, 2024 -7.88%
Jun 30, 2024 3.73%
Mar 31, 2024 6.05%
Dec 31, 2023 -0.37%
Sep 30, 2023 2.51%
Jun 30, 2023 5.83%
Mar 31, 2023 6.70%
Dec 31, 2022 1.18%
Sep 30, 2022 7.50%
Jun 30, 2022 19.75%
Mar 31, 2022 14.42%
Dec 31, 2021 21.36%
Sep 30, 2021 5.41%